Johnson & Johnson (JNJ) Goodwill (2009 - 2026)
Johnson & Johnson's (JNJ) quarterly Goodwill came in at $48.5 billion in Q2 2026, up 0.75% year-over-year from $48.1 billion in Q2 2025, and little changed quarter-over-quarter from $48.6 billion in Q1 2026.
Analysis
Johnson & Johnson (JNJ) Goodwill (2009 - 2026) Analysis & Trends
Johnson & Johnson has disclosed Goodwill across 18 years of filings, most recently posting $48.5 billion for Q2 2026.
- In Q2 2026, Goodwill rose 0.75% year-over-year to $48.5 billion; the TTM figure through Jun 2026 stood at $48.5 billion (up 0.75% YoY), while the FY2025 annual figure was $48.8 billion, up 10.34% from the prior year.
- Goodwill came in at $48.5 billion for Q2 2026 at Johnson & Johnson, roughly flat from $48.6 billion in the prior quarter.
- In the past five years, Goodwill ranged from a high of $48.8 billion in Q4 2025 to a low of $25.4 billion in Q1 2022.
- Average Goodwill over 5 years is $41.3 billion, with a median of $44.2 billion recorded in 2024.
- Year-over-year, Goodwill plunged 30.11% in 2022 and soared 41.72% in 2023.
- Over 5 years, Goodwill stood at $33.4 billion in 2022, then increased by 9.51% to $36.6 billion in 2023, then climbed by 20.9% to $44.2 billion in 2024, then rose by 10.34% to $48.8 billion in 2025, then slipped by 0.6% to $48.5 billion in 2026.
- Per Business Quant data, the three most recent Goodwill figures were $48.5 billion in Q2 2026, $48.6 billion in Q1 2026, and $48.8 billion in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 642.01 Bn | 621.25 Bn | 17.26 Bn |
| 2 | AbbVie | 446.87 Bn | 440.30 Bn | 12.70 Bn |
| 3 | Merck | 358.09 Bn | 350.95 Bn | 12.21 Bn |
| 4 | Novartis Ag | 267.67 Bn | 259.98 Bn | 11.24 Bn |
| 5 | Pfizer | 156.85 Bn | 145.15 Bn | 10.94 Bn |
| 6 | Sanofi | 52.23 Bn | 44.85 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 43.11 Bn | 43.11 Bn | - |
| 8 | Incyte | 24.62 Bn | 20.08 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.29 Bn | 18.62 Bn | 683.80 Mn |
| 10 | Neurocrine Biosciences | 15.88 Bn | 15.49 Bn | 935.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 28, 2026 | 48.48 Bn |
| Mar 29, 2026 | 48.56 Bn |
| Dec 28, 2025 | 48.77 Bn |
| Sep 28, 2025 | 48.05 Bn |
| Jun 29, 2025 | 48.12 Bn |
| Mar 30, 2025 | 44.47 Bn |
| Dec 29, 2024 | 44.20 Bn |
| Sep 29, 2024 | 44.80 Bn |
| Jun 30, 2024 | 44.25 Bn |
| Mar 31, 2024 | 36.62 Bn |
| Dec 31, 2023 | 36.56 Bn |
| Oct 1, 2023 | 36.12 Bn |
| Jul 2, 2023 | 45.44 Bn |
| Apr 2, 2023 | 45.58 Bn |
| Jan 1, 2023 | 36.05 Bn |
| Oct 2, 2022 | 33.38 Bn |
| Jul 3, 2022 | 34.17 Bn |
| Apr 3, 2022 | 34.94 Bn |
| Jan 2, 2022 | 25.44 Bn |
| Oct 3, 2021 | 35.57 Bn |